Newer
Older
Digital_Repository / Misc / Mass downloads / UTas / 1776.html
  1. <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  2. "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
  3. <html>
  4. <head>
  5. <title>UTas ePrints - The tissue factor pathway in ischemic stroke</title>
  6. <script type="text/javascript" src="http://eprints.utas.edu.au/javascript/auto.js"><!-- padder --></script>
  7. <style type="text/css" media="screen">@import url(http://eprints.utas.edu.au/style/auto.css);</style>
  8. <style type="text/css" media="print">@import url(http://eprints.utas.edu.au/style/print.css);</style>
  9. <link rel="icon" href="/images/eprints/favicon.ico" type="image/x-icon" />
  10. <link rel="shortcut icon" href="/images/eprints/favicon.ico" type="image/x-icon" />
  11. <link rel="Top" href="http://eprints.utas.edu.au/" />
  12. <link rel="Search" href="http://eprints.utas.edu.au/cgi/search" />
  13. <meta content="Adams, M.J." name="eprints.creators_name" />
  14. <meta content="Thom, J." name="eprints.creators_name" />
  15. <meta content="Hankey, G.J." name="eprints.creators_name" />
  16. <meta content="Baker, Ross I." name="eprints.creators_name" />
  17. <meta content="Gilmore, G." name="eprints.creators_name" />
  18. <meta content="Staton, J.M." name="eprints.creators_name" />
  19. <meta content="Eikelboom, J.W." name="eprints.creators_name" />
  20. <meta content="article" name="eprints.type" />
  21. <meta content="2007-09-27" name="eprints.datestamp" />
  22. <meta content="2008-01-08 15:30:00" name="eprints.lastmod" />
  23. <meta content="show" name="eprints.metadata_visibility" />
  24. <meta content="The tissue factor pathway in ischemic stroke" name="eprints.title" />
  25. <meta content="pub" name="eprints.ispublished" />
  26. <meta content="321008" name="eprints.subjects" />
  27. <meta content="restricted" name="eprints.full_text_status" />
  28. <meta content="tissue factor, stroke, factor VII, tissue factor pathway inhibitor" name="eprints.keywords" />
  29. <meta content="The definitive version is available online at www.bloodcoagulation.com/" name="eprints.note" />
  30. <meta content="To explore the role of the the tissue factor (TF) pathway in
  31. ischemic stroke. We measured blood concentrations of
  32. markers of the TF pathway [TF antigen, free tissue factor
  33. pathway inhibitor antigen (TFPIf) and activity (TFPIac), and
  34. activated factor VII (FVIIa)] within 7 days (acute phase)
  35. and after 3-6 months (convalescence) in 150 patients with
  36. first-ever ischemic stroke and 150 community controls.
  37. During the acute phase, TF antigen and TFPIf were not
  38. significantly altered but TFPIac was increased (mean 1.27
  39. versus 1.13 U/ml, P U 0.04) and FVIIa was decreased in
  40. cases compared with controls (mean 43.3 versus
  41. 57.9 mU/ml, P U 0.0004). After adjusting for baseline
  42. differences between cases and controls, increasing
  43. quartiles of TFPIf were independently associated with
  44. reduced odds of stroke, and reducing quartiles of FVIIa and
  45. increasing quartiles of TFPIac with increased odds of stroke.
  46. During the convalescent phase, FVIIa and TFPIac returned
  47. to normal but TF antigen and TFPIf were significantly
  48. decreased compared with controls [median TF antigen, 110
  49. (follow-up) versus 155 pg/ml (controls), P U 0.0008;
  50. median TFPIf, 15.5 (follow-up) versus 23.3 ng/ml (controls),
  51. P U 0.002]. Alterations of blood concentrations of TF
  52. pathway markers are common in patients with acute
  53. ischemic stroke. The mechanisms are unclear but may
  54. relate to enhanced formation of TF-FVIIa complexes and
  55. upregulation and release of TFPI during the acute phase,
  56. and ongoing consumption of TF antigen and TFPIf during
  57. the chronic phase as the atherosclerotic plaque heals." name="eprints.abstract" />
  58. <meta content="2006-10" name="eprints.date" />
  59. <meta content="published" name="eprints.date_type" />
  60. <meta content="Blood Coagulation and Fibrinolysis" name="eprints.publication" />
  61. <meta content="17" name="eprints.volume" />
  62. <meta content="7" name="eprints.number" />
  63. <meta content="527-532" name="eprints.pagerange" />
  64. <meta content="10.1097/01.mbc.0000245294.41774.06" name="eprints.id_number" />
  65. <meta content="UNSPECIFIED" name="eprints.thesis_type" />
  66. <meta content="TRUE" name="eprints.refereed" />
  67. <meta content="0957-5235" name="eprints.issn" />
  68. <meta content="http://dx.doi.org/10.1097/01.mbc.0000245294.41774.06" name="eprints.official_url" />
  69. <meta content="1 McVey JH. Tissue Factor Pathway. Baillieres Best Pract Res Clin Haemat
  70. 1999; 12:361-372.
  71. 2 Butenas S, Van't Veer C, Mann KG. Evaluation of the initiation phase of
  72. blood coagulation using ultrasensitive assays for serine proteases. J Biol
  73. Chem 1997; 21:527-521.
  74. 3 Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and
  75. characterisation of a cDNA coding for the lipoprotein-associated
  76. coagulation inhibitor shows that it consists of three tandem kunitz-type
  77. inhibitory domains. J Biol Chem 1988; 263:6001-6004.
  78. 4 Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al.
  79. Functional significance of the kunitz type inhibitor domains of lipoprotein
  80. associated coagulation inhibitor. Nature 1989; 338:518-520.
  81. 5 Kato H. Regulation of functions of vascular wall cells by tissue factor
  82. pathway inhibitor. Arterioscler Thromb Vasc Biol 2002; 22:539-548.
  83. 6 Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor
  84. pathway inhibitor. Blood Coagul Fibrinolysis 1992; 3:439-449.
  85. 7 Hubbard AR, Jennings CA. Inhibition of the tissue factor-factor VIIa
  86. complex: involvement of factor Xa and lipoproteins. Thromb Res 1987; 46:
  87. 527-537.
  88. 8 Novotny WF, Girard TF, Miletich JP, Broze GJ. Purification and
  89. characterisation of the lipoprotein-associated coagulation inhibitor from
  90. human plasma. J Biol Chem 1989; 264:18832-18837.
  91. 9 Novotny WF, Girard TF, Miletich JP, Broze GJ. Platelets secrete a
  92. coagulation inhibitor functionally and antigenically similar to the lipoprotein
  93. associated coagulation inhibitor. Blood 1988; 72:2020-2025.
  94. 10 Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M. Involvement of
  95. tissue factor pathway inhibitor in the coronary circulation of patients with
  96. acute coronary syndromes. Circulation 2003; 108:2864-2869.
  97. 11 Abumiya T, Yamaguchi T, Terasaki T, Kokawa T, Kario K, Kato H. Decreased
  98. plasma tissue factor pathway inhibitor activity in ischemic stroke patients.
  99. Thromb Haemost 1995; 74:1050-1054.
  100. 12 He M, Wen Z, He X, Xiong S, Liu F, Xu J, et al. Observation on tissue factor
  101. pathway and some other coagulation parameters during the onset of acute
  102. cerebrocardiac thrombotic diseases. Thromb Res 2002; 107:223-
  103. 228.
  104. TF pathway and stroke Adams et al. 531
  105. Copyright Lippincott Williams &amp; Wilkins. Unauthorized reproduction of this article is prohibited.
  106. 13 Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI.
  107. Association between high homocysteine and ischemic stroke due to large
  108. and small artery disease but not other etiological subtypes of ischemic
  109. stroke. Stroke 2000; 31:1069-1075.
  110. 14 Hatano S. Experience from a multicentre stroke register: a preliminary
  111. report. Bull World Health Org 1976; 54:541-553.
  112. 15 Warlow CP, Dennis MS, Van Gijn J, Hankey GJ, Sandercock PAG,
  113. Bamford JM. Stroke: a practical guide to management, 2nd ed. Oxford:
  114. Blackwell Scientific Productions; 2000.
  115. 16 Sandset PM, Larsen ML, Abildaard U, Odegaard OR. Chromogenic
  116. substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal
  117. population and relation to cholesterol. Blood Coagul Fibrinolysis 1991;
  118. 2:425-433.
  119. 17 Eilertsen KE, Osterud B. Tissue factor: (patho)physiology and cellular
  120. biology. Blood Coagul Fibrinolysis 2004; 15:521-538.
  121. 18 Lindmark E, Siegbahn A. Tissue factor regulation and cytokine expression
  122. in monocyte-endothelial cell co-cultures: effects of a statin, an ACEinhibitor
  123. and a low-molecular-weight heparin. Thromb Res 2002; 108:
  124. 77-84.
  125. 19 Kopp CW, Steiner S, Priglinger U, Christ G, Probst P, Maurer G, et al.
  126. Parameters of the tissue factor pathway with coumadin/dipyridamole
  127. versus ticlopidine as adjunct antithrombotic-drug regimen in coronary
  128. artery stenting. Blood Coagul Fibrinolysis 2003; 14:379-386.
  129. 20 Sebestjen M, Keber I, Zegura B, Simcic S, Bozic M, Fressart MM, et al.
  130. Statin and fibrate treatment of combined hyperlipidemia: the effects on
  131. some novel risk factors. Thromb Haemost 2004; 92:1129-1135.
  132. 21 Bartok A, Steiner S, Seidinger D, Jetzl A, Huber K, Minar E, et al.
  133. Atorvastatin reduces thrombin generation after percutaneous coronary
  134. intervention independent of soluble tissue factor. Thromb Res 2005;
  135. 115:469-474.
  136. 22 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR,
  137. et al. Haemostatic function and ischaemic heart disease: principal results of
  138. the Northwick Park Heart Study. Lancet 1986; 2:533-537.
  139. 23 Kario K, Duell PB, Matsuo T, Sakata T, Kato H, Shimada K, et al. High
  140. plasma homocysteine levels in elderly Japanese patients are associated
  141. with increased cardiovascular disease risk independently from markers of
  142. coagulation activation and endothelial cell damage. Atherosclerosis 2001;
  143. 157:441-449.
  144. 24 Kang WY, Wang HL, Xiong LF, Wang XF, Chu HY, Qu B, et al.
  145. Polymorphisms of the coagulation factor VII gene and its plasma levels in
  146. relation to acute cerebral infarction differences in allelic frequencies
  147. between Chinese Han and European populations. Chin Med J (Engl)
  148. 2004; 117:71-74.
  149. 25 Dahm AE, Andersen TO, Rosendaal F, Sandset PM. A novel anticoagulant
  150. activity assay of tissue factor pathway inhibitor I (TFPI). J Thromb Haemost
  151. 2005; 3:651-658.
  152. 26 Hansen JB, Huseby KR, Huseby NE, Ezban M, Nordoy A. Tissue factor
  153. pathway inhibitor in complex with low density lipoprotein isolated from
  154. human plasma does not possess anticoagulant function in tissue factorinduced
  155. coagulation in vitro. Thromb Res 1997; 85:413-425.
  156. 27 Hirsh J, O'Donnell M, Weitz JI. New anticoagulants. Blood 2005; 105:
  157. 453-463." name="eprints.referencetext" />
  158. <meta content="Adams, M.J. and Thom, J. and Hankey, G.J. and Baker, Ross I. and Gilmore, G. and Staton, J.M. and Eikelboom, J.W. (2006) The tissue factor pathway in ischemic stroke. Blood Coagulation and Fibrinolysis, 17 (7). pp. 527-532. ISSN 0957-5235" name="eprints.citation" />
  159. <meta content="http://eprints.utas.edu.au/1776/1/Adams_et_al_2006.pdf" name="eprints.document_url" />
  160. <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" />
  161. <meta content="The tissue factor pathway in ischemic stroke" name="DC.title" />
  162. <meta content="Adams, M.J." name="DC.creator" />
  163. <meta content="Thom, J." name="DC.creator" />
  164. <meta content="Hankey, G.J." name="DC.creator" />
  165. <meta content="Baker, Ross I." name="DC.creator" />
  166. <meta content="Gilmore, G." name="DC.creator" />
  167. <meta content="Staton, J.M." name="DC.creator" />
  168. <meta content="Eikelboom, J.W." name="DC.creator" />
  169. <meta content="321008 Haematology" name="DC.subject" />
  170. <meta content="To explore the role of the the tissue factor (TF) pathway in
  171. ischemic stroke. We measured blood concentrations of
  172. markers of the TF pathway [TF antigen, free tissue factor
  173. pathway inhibitor antigen (TFPIf) and activity (TFPIac), and
  174. activated factor VII (FVIIa)] within 7 days (acute phase)
  175. and after 3-6 months (convalescence) in 150 patients with
  176. first-ever ischemic stroke and 150 community controls.
  177. During the acute phase, TF antigen and TFPIf were not
  178. significantly altered but TFPIac was increased (mean 1.27
  179. versus 1.13 U/ml, P U 0.04) and FVIIa was decreased in
  180. cases compared with controls (mean 43.3 versus
  181. 57.9 mU/ml, P U 0.0004). After adjusting for baseline
  182. differences between cases and controls, increasing
  183. quartiles of TFPIf were independently associated with
  184. reduced odds of stroke, and reducing quartiles of FVIIa and
  185. increasing quartiles of TFPIac with increased odds of stroke.
  186. During the convalescent phase, FVIIa and TFPIac returned
  187. to normal but TF antigen and TFPIf were significantly
  188. decreased compared with controls [median TF antigen, 110
  189. (follow-up) versus 155 pg/ml (controls), P U 0.0008;
  190. median TFPIf, 15.5 (follow-up) versus 23.3 ng/ml (controls),
  191. P U 0.002]. Alterations of blood concentrations of TF
  192. pathway markers are common in patients with acute
  193. ischemic stroke. The mechanisms are unclear but may
  194. relate to enhanced formation of TF-FVIIa complexes and
  195. upregulation and release of TFPI during the acute phase,
  196. and ongoing consumption of TF antigen and TFPIf during
  197. the chronic phase as the atherosclerotic plaque heals." name="DC.description" />
  198. <meta content="2006-10" name="DC.date" />
  199. <meta content="Article" name="DC.type" />
  200. <meta content="PeerReviewed" name="DC.type" />
  201. <meta content="application/pdf" name="DC.format" />
  202. <meta content="http://eprints.utas.edu.au/1776/1/Adams_et_al_2006.pdf" name="DC.identifier" />
  203. <meta content="http://dx.doi.org/10.1097/01.mbc.0000245294.41774.06" name="DC.relation" />
  204. <meta content="Adams, M.J. and Thom, J. and Hankey, G.J. and Baker, Ross I. and Gilmore, G. and Staton, J.M. and Eikelboom, J.W. (2006) The tissue factor pathway in ischemic stroke. Blood Coagulation and Fibrinolysis, 17 (7). pp. 527-532. ISSN 0957-5235" name="DC.identifier" />
  205. <meta content="http://eprints.utas.edu.au/1776/" name="DC.relation" />
  206. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/BibTeX/epprod-eprint-1776.bib" title="BibTeX" type="text/plain" />
  207. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/ContextObject/epprod-eprint-1776.xml" title="OpenURL ContextObject" type="text/xml" />
  208. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/ContextObject::Dissertation/epprod-eprint-1776.xml" title="OpenURL Dissertation" type="text/xml" />
  209. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/ContextObject::Journal/epprod-eprint-1776.xml" title="OpenURL Journal" type="text/xml" />
  210. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/DC/epprod-eprint-1776.txt" title="Dublin Core" type="text/plain" />
  211. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/DIDL/epprod-eprint-1776.xml" title="DIDL" type="text/xml" />
  212. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/EndNote/epprod-eprint-1776.enw" title="EndNote" type="text/plain" />
  213. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/HTML/epprod-eprint-1776.html" title="HTML Citation" type="text/html; charset=utf-8" />
  214. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/METS/epprod-eprint-1776.xml" title="METS" type="text/xml" />
  215. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/MODS/epprod-eprint-1776.xml" title="MODS" type="text/xml" />
  216. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/RIS/epprod-eprint-1776.ris" title="Reference Manager" type="text/plain" />
  217. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/Refer/epprod-eprint-1776.refer" title="Refer" type="text/plain" />
  218. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/Simple/epprod-eprint-1776text" title="Simple Metadata" type="text/plain" />
  219. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/Text/epprod-eprint-1776.txt" title="ASCII Citation" type="text/plain; charset=utf-8" />
  220. <link rel="alternate" href="http://eprints.utas.edu.au/cgi/export/1776/XML/epprod-eprint-1776.xml" title="EP3 XML" type="text/xml" />
  221.  
  222. </head>
  223. <body bgcolor="#ffffff" text="#000000" onLoad="loadRoutine(); MM_preloadImages('images/eprints/ePrints_banner_r5_c5_f2.gif','images/eprints/ePrints_banner_r5_c7_f2.gif','images/eprints/ePrints_banner_r5_c8_f2.gif','images/eprints/ePrints_banner_r5_c9_f2.gif','images/eprints/ePrints_banner_r5_c10_f2.gif','images/eprints/ePrints_banner_r5_c11_f2.gif','images/eprints/ePrints_banner_r6_c4_f2.gif')">
  224. <div class="ep_noprint"><noscript><style type="text/css">@import url(http://eprints.utas.edu.au/style/nojs.css);</style></noscript></div>
  225.  
  226.  
  227.  
  228.  
  229. <table width="795" border="0" cellspacing="0" cellpadding="0">
  230. <tr>
  231. <td><script language="JavaScript1.2">mmLoadMenus();</script>
  232. <table border="0" cellpadding="0" cellspacing="0" width="795">
  233. <!-- fwtable fwsrc="eprints_banner_final2.png" fwbase="ePrints_banner.gif" fwstyle="Dreamweaver" fwdocid = "1249563342" fwnested="0" -->
  234. <tr>
  235. <td><img src="/images/eprints/spacer.gif" width="32" height="1" border="0" alt="" /></td>
  236. <td><img src="/images/eprints/spacer.gif" width="104" height="1" border="0" alt="" /></td>
  237. <td><img src="/images/eprints/spacer.gif" width="44" height="1" border="0" alt="" /></td>
  238. <td><img src="/images/eprints/spacer.gif" width="105" height="1" border="0" alt="" /></td>
  239. <td><img src="/images/eprints/spacer.gif" width="41" height="1" border="0" alt="" /></td>
  240. <td><img src="/images/eprints/spacer.gif" width="16" height="1" border="0" alt="" /></td>
  241. <td><img src="/images/eprints/spacer.gif" width="68" height="1" border="0" alt="" /></td>
  242. <td><img src="/images/eprints/spacer.gif" width="68" height="1" border="0" alt="" /></td>
  243. <td><img src="/images/eprints/spacer.gif" width="68" height="1" border="0" alt="" /></td>
  244. <td><img src="/images/eprints/spacer.gif" width="82" height="1" border="0" alt="" /></td>
  245. <td><img src="/images/eprints/spacer.gif" width="69" height="1" border="0" alt="" /></td>
  246. <td><img src="/images/eprints/spacer.gif" width="98" height="1" border="0" alt="" /></td>
  247. <td><img src="/images/eprints/spacer.gif" width="1" height="1" border="0" alt="" /></td>
  248. </tr>
  249. <tr>
  250. <td colspan="12"><img name="ePrints_banner_r1_c1" src="/images/eprints/ePrints_banner_r1_c1.gif" width="795" height="10" border="0" alt="" /></td>
  251. <td><img src="/images/eprints/spacer.gif" width="1" height="10" border="0" alt="" /></td>
  252. </tr>
  253. <tr>
  254. <td rowspan="6"><img name="ePrints_banner_r2_c1" src="/images/eprints/ePrints_banner_r2_c1.gif" width="32" height="118" border="0" alt="" /></td>
  255. <td rowspan="5"><a href="http://www.utas.edu.au/"><img name="ePrints_banner_r2_c2" src="/images/eprints/ePrints_banner_r2_c2.gif" width="104" height="103" border="0" alt="" /></a></td>
  256. <td colspan="10"><img name="ePrints_banner_r2_c3" src="/images/eprints/ePrints_banner_r2_c3.gif" width="659" height="41" border="0" alt="" /></td>
  257. <td><img src="/images/eprints/spacer.gif" width="1" height="41" border="0" alt="" /></td>
  258. </tr>
  259. <tr>
  260. <td colspan="3"><a href="http://eprints.utas.edu.au/"><img name="ePrints_banner_r3_c3" src="/images/eprints/ePrints_banner_r3_c3.gif" width="190" height="31" border="0" alt="" /></a></td>
  261. <td rowspan="2" colspan="7"><img name="ePrints_banner_r3_c6" src="/images/eprints/ePrints_banner_r3_c6.gif" width="469" height="37" border="0" alt="" /></td>
  262. <td><img src="/images/eprints/spacer.gif" width="1" height="31" border="0" alt="" /></td>
  263. </tr>
  264. <tr>
  265. <td colspan="3"><img name="ePrints_banner_r4_c3" src="/images/eprints/ePrints_banner_r4_c3.gif" width="190" height="6" border="0" alt="" /></td>
  266. <td><img src="/images/eprints/spacer.gif" width="1" height="6" border="0" alt="" /></td>
  267. </tr>
  268. <tr>
  269. <td colspan="2"><img name="ePrints_banner_r5_c3" src="/images/eprints/ePrints_banner_r5_c3.gif" width="149" height="1" border="0" alt="" /></td>
  270. <td rowspan="2" colspan="2"><a href="/information.html" onMouseOut="MM_swapImgRestore();MM_startTimeout()" onMouseOver="MM_showMenu(window.mm_menu_0821132634_0,0,25,null,'ePrints_banner_r5_c5');MM_swapImage('ePrints_banner_r5_c5','','/images/eprints/ePrints_banner_r5_c5_f2.gif',1);"><img name="ePrints_banner_r5_c5" src="/images/eprints/ePrints_banner_r5_c5.gif" width="57" height="25" border="0" alt="About" /></a></td>
  271. <td rowspan="2"><a href="/view/" onMouseOut="MM_swapImgRestore();MM_startTimeout()" onMouseOver="MM_showMenu(window.mm_menu_0821133021_1,0,25,null,'ePrints_banner_r5_c7');MM_swapImage('ePrints_banner_r5_c7','','/images/eprints/ePrints_banner_r5_c7_f2.gif',1);"><img name="ePrints_banner_r5_c7" src="/images/eprints/ePrints_banner_r5_c7.gif" width="68" height="25" border="0" alt="Browse" /></a></td>
  272. <td rowspan="2"><a href="/perl/search/simple" onMouseOut="MM_swapImgRestore();MM_startTimeout()" onMouseOver="MM_showMenu(window.mm_menu_0821133201_2,0,25,null,'ePrints_banner_r5_c8');MM_swapImage('ePrints_banner_r5_c8','','/images/eprints/ePrints_banner_r5_c8_f2.gif',1);"><img name="ePrints_banner_r5_c8" src="/images/eprints/ePrints_banner_r5_c8.gif" width="68" height="25" border="0" alt="Search" /></a></td>
  273. <td rowspan="2"><a href="/perl/register" onMouseOut="MM_swapImgRestore();MM_startTimeout();" onMouseOver="MM_showMenu(window.mm_menu_1018171924_3,0,25,null,'ePrints_banner_r5_c9');MM_swapImage('ePrints_banner_r5_c9','','/images/eprints/ePrints_banner_r5_c9_f2.gif',1);"><img name="ePrints_banner_r5_c9" src="/images/eprints/ePrints_banner_r5_c9.gif" width="68" height="25" border="0" alt="register" /></a></td>
  274. <td rowspan="2"><a href="/perl/users/home" onMouseOut="MM_swapImgRestore();MM_startTimeout()" onMouseOver="MM_showMenu(window.mm_menu_0821133422_4,0,25,null,'ePrints_banner_r5_c10');MM_swapImage('ePrints_banner_r5_c10','','/images/eprints/ePrints_banner_r5_c10_f2.gif',1);"><img name="ePrints_banner_r5_c10" src="/images/eprints/ePrints_banner_r5_c10.gif" width="82" height="25" border="0" alt="user area" /></a></td>
  275. <td rowspan="2"><a href="/help/" onMouseOut="MM_swapImgRestore();MM_startTimeout()" onMouseOver="MM_showMenu(window.mm_menu_0821133514_5,0,25,null,'ePrints_banner_r5_c11');MM_swapImage('ePrints_banner_r5_c11','','/images/eprints/ePrints_banner_r5_c11_f2.gif',1);"><img name="ePrints_banner_r5_c11" src="/images/eprints/ePrints_banner_r5_c11.gif" width="69" height="25" border="0" alt="Help" /></a></td>
  276. <td rowspan="3" colspan="4"><img name="ePrints_banner_r5_c12" src="/images/eprints/ePrints_banner_r5_c12.gif" width="98" height="40" border="0" alt="" /></td>
  277. <td><img src="/images/eprints/spacer.gif" width="1" height="1" border="0" alt="" /></td>
  278. </tr>
  279. <tr>
  280. <td rowspan="2"><img name="ePrints_banner_r6_c3" src="/images/eprints/ePrints_banner_r6_c3.gif" width="44" height="39" border="0" alt="ePrints home" /></td>
  281. <td><a href="/" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('ePrints_banner_r6_c4','','/images/eprints/ePrints_banner_r6_c4_f2.gif',1);"><img name="ePrints_banner_r6_c4" src="/images/eprints/ePrints_banner_r6_c4.gif" width="105" height="24" border="0" alt="ePrints home" /></a></td>
  282. <td><img src="/images/eprints/spacer.gif" width="1" height="24" border="0" alt="" /></td>
  283. </tr>
  284. <tr>
  285. <td><img name="ePrints_banner_r7_c2" src="/images/eprints/ePrints_banner_r7_c2.gif" width="104" height="15" border="0" alt="" /></td>
  286. <td colspan="8"><img name="ePrints_banner_r7_c4" src="/images/eprints/ePrints_banner_r7_c4.gif" width="517" height="15" border="0" alt="" /></td>
  287. <td><img src="/images/eprints/spacer.gif" width="1" height="15" border="0" alt="" /></td>
  288. </tr>
  289. </table></td>
  290. </tr>
  291. <tr><td><table width="100%" style="font-size: 90%; border: solid 1px #ccc; padding: 3px"><tr>
  292. <td align="left"><a href="http://eprints.utas.edu.au/cgi/users/home">Login</a> | <a href="http://eprints.utas.edu.au/cgi/register">Create Account</a></td>
  293. <td align="right" style="white-space: nowrap">
  294. <form method="get" accept-charset="utf-8" action="http://eprints.utas.edu.au/cgi/search" style="display:inline">
  295. <input class="ep_tm_searchbarbox" size="20" type="text" name="q" />
  296. <input class="ep_tm_searchbarbutton" value="Search" type="submit" name="_action_search" />
  297. <input type="hidden" name="_order" value="bytitle" />
  298. <input type="hidden" name="basic_srchtype" value="ALL" />
  299. <input type="hidden" name="_satisfyall" value="ALL" />
  300. </form>
  301. </td>
  302. </tr></table></td></tr>
  303. <tr>
  304. <td class="toplinks"><!-- InstanceBeginEditable name="content" -->
  305.  
  306.  
  307. <div align="center">
  308. <table width="720" class="ep_tm_main"><tr><td align="left">
  309. <h1 class="ep_tm_pagetitle">The tissue factor pathway in ischemic stroke</h1>
  310. <p style="margin-bottom: 1em" class="not_ep_block"><span class="person_name">Adams, M.J.</span> and <span class="person_name">Thom, J.</span> and <span class="person_name">Hankey, G.J.</span> and <span class="person_name">Baker, Ross I.</span> and <span class="person_name">Gilmore, G.</span> and <span class="person_name">Staton, J.M.</span> and <span class="person_name">Eikelboom, J.W.</span> (2006) <xhtml:em>The tissue factor pathway in ischemic stroke.</xhtml:em> Blood Coagulation and Fibrinolysis, 17 (7). pp. 527-532. ISSN 0957-5235</p><p style="margin-bottom: 1em" class="not_ep_block"></p><table style="margin-bottom: 1em" class="not_ep_block"><tr><td valign="top" style="text-align:center"><a href="http://eprints.utas.edu.au/1776/1/Adams_et_al_2006.pdf"><img alt="[img]" src="http://eprints.utas.edu.au/style/images/fileicons/application_pdf.png" class="ep_doc_icon" border="0" /></a></td><td valign="top"><a href="http://eprints.utas.edu.au/1776/1/Adams_et_al_2006.pdf"><span class="ep_document_citation">PDF</span></a> - Full text restricted - Requires a PDF viewer<br />166Kb</td></tr></table><p style="margin-bottom: 1em" class="not_ep_block">Official URL: <a href="http://dx.doi.org/10.1097/01.mbc.0000245294.41774.06">http://dx.doi.org/10.1097/01.mbc.0000245294.41774.06</a></p><div class="not_ep_block"><h2>Abstract</h2><p style="padding-bottom: 16px; text-align: left; margin: 1em auto 0em auto">To explore the role of the the tissue factor (TF) pathway in&#13;
  311. ischemic stroke. We measured blood concentrations of&#13;
  312. markers of the TF pathway [TF antigen, free tissue factor&#13;
  313. pathway inhibitor antigen (TFPIf) and activity (TFPIac), and&#13;
  314. activated factor VII (FVIIa)] within 7 days (acute phase)&#13;
  315. and after 3-6 months (convalescence) in 150 patients with&#13;
  316. first-ever ischemic stroke and 150 community controls.&#13;
  317. During the acute phase, TF antigen and TFPIf were not&#13;
  318. significantly altered but TFPIac was increased (mean 1.27&#13;
  319. versus 1.13 U/ml, P U 0.04) and FVIIa was decreased in&#13;
  320. cases compared with controls (mean 43.3 versus&#13;
  321. 57.9 mU/ml, P U 0.0004). After adjusting for baseline&#13;
  322. differences between cases and controls, increasing&#13;
  323. quartiles of TFPIf were independently associated with&#13;
  324. reduced odds of stroke, and reducing quartiles of FVIIa and&#13;
  325. increasing quartiles of TFPIac with increased odds of stroke.&#13;
  326. During the convalescent phase, FVIIa and TFPIac returned&#13;
  327. to normal but TF antigen and TFPIf were significantly&#13;
  328. decreased compared with controls [median TF antigen, 110&#13;
  329. (follow-up) versus 155 pg/ml (controls), P U 0.0008;&#13;
  330. median TFPIf, 15.5 (follow-up) versus 23.3 ng/ml (controls),&#13;
  331. P U 0.002]. Alterations of blood concentrations of TF&#13;
  332. pathway markers are common in patients with acute&#13;
  333. ischemic stroke. The mechanisms are unclear but may&#13;
  334. relate to enhanced formation of TF-FVIIa complexes and&#13;
  335. upregulation and release of TFPI during the acute phase,&#13;
  336. and ongoing consumption of TF antigen and TFPIf during&#13;
  337. the chronic phase as the atherosclerotic plaque heals.</p></div><table style="margin-bottom: 1em" cellpadding="3" class="not_ep_block" border="0"><tr><th valign="top" class="ep_row">Item Type:</th><td valign="top" class="ep_row">Article</td></tr><tr><th valign="top" class="ep_row">Additional Information:</th><td valign="top" class="ep_row">The definitive version is available online at www.bloodcoagulation.com/</td></tr><tr><th valign="top" class="ep_row">Keywords:</th><td valign="top" class="ep_row">tissue factor, stroke, factor VII, tissue factor pathway inhibitor</td></tr><tr><th valign="top" class="ep_row">Subjects:</th><td valign="top" class="ep_row"><a href="http://eprints.utas.edu.au/view/subjects/321008.html">320000 Medical and Health Sciences &gt; 321000 Clinical Sciences &gt; 321008 Haematology</a></td></tr><tr><th valign="top" class="ep_row">ID Code:</th><td valign="top" class="ep_row">1776</td></tr><tr><th valign="top" class="ep_row">Deposited By:</th><td valign="top" class="ep_row"><span class="ep_name_citation"><span class="person_name">Dr Murray J Adams</span></span></td></tr><tr><th valign="top" class="ep_row">Deposited On:</th><td valign="top" class="ep_row">27 Sep 2007</td></tr><tr><th valign="top" class="ep_row">Last Modified:</th><td valign="top" class="ep_row">09 Jan 2008 02:30</td></tr><tr><th valign="top" class="ep_row">ePrint Statistics:</th><td valign="top" class="ep_row"><a target="ePrintStats" href="/es/index.php?action=show_detail_eprint;id=1776;">View statistics for this ePrint</a></td></tr></table><p align="right">Repository Staff Only: <a href="http://eprints.utas.edu.au/cgi/users/home?screen=EPrint::View&amp;eprintid=1776">item control page</a></p>
  338. </td></tr></table>
  339. </div>
  340.  
  341.  
  342.  
  343. <!-- InstanceEndEditable --></td>
  344. </tr>
  345. <tr>
  346. <td><!-- #BeginLibraryItem "/Library/footer_eprints.lbi" -->
  347. <table width="795" border="0" align="left" cellpadding="0" class="footer">
  348. <tr valign="top">
  349. <td colspan="2"><div align="center"><a href="http://www.utas.edu.au">UTAS home</a> | <a href="http://www.utas.edu.au/library/">Library home</a> | <a href="/">ePrints home</a> | <a href="/contact.html">contact</a> | <a href="/information.html">about</a> | <a href="/view/">browse</a> | <a href="/perl/search/simple">search</a> | <a href="/perl/register">register</a> | <a href="/perl/users/home">user area</a> | <a href="/help/">help</a></div><br /></td>
  350. </tr>
  351. <tr><td colspan="2"><p><img src="/images/eprints/footerline.gif" width="100%" height="4" /></p></td></tr>
  352. <tr valign="top">
  353. <td width="68%" class="footer">Authorised by the University Librarian<br />
  354. © University of Tasmania ABN 30 764 374 782<br />
  355. <a href="http://www.utas.edu.au/cricos/">CRICOS Provider Code 00586B</a> | <a href="http://www.utas.edu.au/copyright/copyright_disclaimers.html">Copyright &amp; Disclaimers</a> | <a href="http://www.utas.edu.au/accessibility/index.html">Accessibility</a> | <a href="http://eprints.utas.edu.au/feedback/">Site Feedback</a>  </td>
  356. <td width="32%"><div align="right">
  357. <p align="right" class="NoPrint"><a href="http://www.utas.edu.au/"><img src="http://www.utas.edu.au/shared/logos/unioftasstrip.gif" alt="University of Tasmania Home Page" width="260" height="16" border="0" align="right" /></a></p>
  358. <p align="right" class="NoPrint"><a href="http://www.utas.edu.au/"><br />
  359. </a></p>
  360. </div></td>
  361. </tr>
  362. <tr valign="top">
  363. <td><p>  </p></td>
  364. <td><div align="right"><span class="NoPrint"><a href="http://www.eprints.org/software/"><img src="/images/eprintslogo.gif" alt="ePrints logo" width="77" height="29" border="0" align="bottom" /></a></span></div></td>
  365. </tr>
  366. </table>
  367. <!-- #EndLibraryItem -->
  368. <div align="center"></div></td>
  369. </tr>
  370. </table>
  371.  
  372. </body>
  373. </html>